본문 바로가기
KERD
논문KCI 등재

Oxytocin Levels in Children with Separation Anxiety and Their Mothers before and after Treatment

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Objective: The purpose of this study was to compare the plasma oxytocin levels of children with separation anxiety disorder (SAD) and their mothers with those of healthy controls and to examine the relationship between oxytocin levels and changes in anxiety three months after treatment. Methods: Thirty children aged 6−12 years with SAD, 30 healthy children, and mothers of both groups were included in the study. All cases were evaluated with semi-structured interview and Clinical Global Impression Scale. All cases and mothers of both groups filled out scales to determine various psychological variables (anxiety, depression, and attachment). The patient group children were re-evaluated with their mothers after three months, following treatment. Plasma oxytocin levels were evaluated from both groups and their mothers before and after treatment. Results: The plasma oxytocin levels of mothers of children with SAD were significantly lower than those of the controls and increased significantly three months after their children were treated. No difference was found between the plasma oxytocin levels of children with SAD and the control group, and these children’s levels decreased significantly after treatment. A positive correlation was found between changes in the plasma oxytocin levels of children with SAD and the change in anxiety scores. Conclusion: Our results show that the change in plasma oxytocin levels in both children and mothers after treatment suggests that oxytocin may be important in the etiology of SAD.

Abstract

Objective: The purpose of this study was to compare the plasma oxytocin levels of children with separation anxiety disorder (SAD) and their mothers with those of healthy controls and to examine the relationship between oxytocin levels and changes in anxiety three months after treatment. Methods: Thirty children aged 6−12 years with SAD, 30 healthy children, and mothers of both groups were included in the study. All cases were evaluated with semi-structured interview and Clinical Global Impression Scale. All cases and mothers of both groups filled out scales to determine various psychological variables (anxiety, depression, and attachment). The patient group children were re-evaluated with their mothers after three months, following treatment. Plasma oxytocin levels were evaluated from both groups and their mothers before and after treatment. Results: The plasma oxytocin levels of mothers of children with SAD were significantly lower than those of the controls and increased significantly three months after their children were treated. No difference was found between the plasma oxytocin levels of children with SAD and the control group, and these children’s levels decreased significantly after treatment. A positive correlation was found between changes in the plasma oxytocin levels of children with SAD and the change in anxiety scores. Conclusion: Our results show that the change in plasma oxytocin levels in both children and mothers after treatment suggests that oxytocin may be important in the etiology of SAD.

참고문헌 (60)

  1. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (2013), American Psychiatric Publishing
  2. Connolly SD, "Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders", J Am Acad Child Adolesc Psychiatry, 46, pp.267~283 (2007)
  3. Cartwright-Hatton S, "Anxiety in a neglected population : Prevalence of anxiety disorders in pre-adolescent children", Clin Psychol Rev, 26, pp.817~833 (2006)
  4. Kessler RC, "Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication", Arch Gen Psychiatry, 62, pp.593~602 (2005)
  5. Bögels SM, "Family cognitive behavioral therapy for children and adolescents with clinical anxiety disorders", J Am Acad Child Adolesc Psychiatry, 45, pp.134~141 (2006)
  6. Manassis K, "Attachment in mothers with anxiety disorders and their children", J Am Acad Child Adolesc Psychiatry, 33, pp.1106~1113 (1994)
  7. Buchheim A, "Oxytocin enhances the experience of attachment security", Psychoneuroendocrinology, 34, pp.1417~1422 (2009)
  8. Carter CS, "Neuroendocrine perspectives on social attachment and love", Psychoneuroendocrinology, 23, pp.779~818 (1998)
  9. Legros JJ, "Inhibitory effect of oxytocin on corticotrope function in humans : Are vasopressin and oxytocin ying-yang neurohormones?", Psychoneuroendocrinology, 26, pp.649~655 (2001)
  10. Heinrichs M, "Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress", Biol Psychiatry, 54, pp.1389~1398 (2003)
  11. Ditzen B, "Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict", Biol Psychiatry, 65, pp.728~731 (2009)
  12. Francesca De Cagna, "The Role of Intranasal Oxytocin in Anxiety and Depressive Disorders: A Systematic Review of Randomized Controlled Trials", Clinical Psychopharmacology and Neuroscience, 17(1), pp.1~11 (2019), 대한정신약물학회[DOI]
  13. Carson DS, "Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children", Mol Psychiatry, 20, pp.1085~1090 (2015)
  14. Weisman O, "Plasma oxytocin distributions in a large cohort of women and men and their gender-specific associations with anxiety", Psychoneuroendocrinology, 38, pp.694~701 (2013)
  15. Bernhard A, "Adolescent oxytocin response to stress and its behavioral and endocrine correlates", Horm Behav, 105, pp.157~165 (2018)
  16. Levine A, "Oxytocin during pregnancy and early postpartum : Individual patterns and maternal-fetal attachment", Peptides, 28, pp.1162~1169 (2007)
  17. Strathearn L, "Adult attachment predicts maternal brain and oxytocin response to infant cues", Neuropsychopharmacology, 34, pp.2655~2666 (2009)
  18. Lebowitz ER, "Salivary oxytocin in clinically anxious youth : Associations with separation anxiety and family accommodation", Psychoneuroendocrinology, 65, pp.35~43 (2016)
  19. Gottschalk MG, "Oxytocin and anxiety disorders", Curr Top Behav Neurosci, 35, pp.467~498 (2018)
  20. Lebowitz ER, "Oxytocin response to youth-mother interactions in clinically anxious youth is associated with separation anxiety and dyadic behavior", Depress Anxiety, 34, pp.127~136 (2017)
  21. Kang Seob Oh, "The Relationship between Plasma Oxytocin Levels and Social Anxiety Symptoms", PSYCHIATRY INVESTIGATION, 15(11), pp.1079~1086 (2018), 대한신경정신의학회[DOI]
  22. Hoge EA, "Plasma oxytocin immunoreactive products and response to trust in patients with social anxiety disorder", Depress Anxiety, 29, pp.924~930 (2012)
  23. Milrod B, "Adult separation anxiety in treatment nonresponders with anxiety disorders : Delineation of the syndrome and exploration of attachment-based psychotherapy and biomarkers", Compr Psychiatry, 66, pp.139~145 (2016)
  24. Ünal F, "Reliability and Validity of the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version, DSM-5November 2016-Turkish Adaptation(K-SADS-PL-DSM-5-T)", Türk Psikiyatri Dergisi, 30, pp.42~50 (2019)
  25. Gormez V, "Psychometric properties of the Turkish version of the Revised Child Anxiety and Depression Scale – Child Version in a clinical sample", Psychiatry Clin Psychopharmacol, 27, pp.84~92 (2017)
  26. Teze S, "Examination on the validty and reliability of separation anxiety assessment scale children’s", parents’ forms, 2016, pp.48, 333~344
  27. Kırımer F, "Anxious and avoidant attachment to mother in middle childhood : Turkish adaptation of the Experiences in Close Relationships Inventory-II Middle Childhood Scale", Türk Psikoloji Yazıları, 17, pp.45~57 (2014)
  28. Diriöz M, "The validity and reliability of Turkish version of separation anxiety symptom inventory and adult separation anxiety questionnaire", Turk Psikiyatri Derg, 23, pp.108~116 (2012)
  29. Akdemir A, "Validity, reliability and clinical use of the Hamilton depression rating scale", Psikiyatr Psikol Psikofarmakol Derg, 4, pp.251~259 (1996)
  30. Yazıcı K, "Hamilton anxiety rating scale, inter-rater reliability and validity study", Türk Psikiyatr Derg, 9, pp.114~117 (1998)
  31. Guy W, "ECDEU Assessment manual for psychopharmacology", pp.217~222 (1976), Department of Health, Education, and Welfare
  32. Ambrosini PJ, "Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children(K-SADS)", J Am Acad Child Adolesc Psychiatry, 39, pp.49~58 (2000)
  33. Chorpita BF, "Psychometric properties of the Revised Child Anxiety and Depression Scale in a clinical sample", Behav Res Ther, 43, pp.309~322 (2005)
  34. Hahn L, "Measuring the dimensions of separation anxiety and early panic in children and adolescents: The Separation Anxiety Assessment Scale", 37th Annual Convention of the Association for the Advancement of Behavior Therapy (2003)
  35. Eisen AR, "Separation anxiety in children and adolescents: An individualized approach to assessment and treatment", pp.298~ (2005), Guilford Press
  36. Brenning K, "An adaptation of the Experiences in Close Relationships Scale-Revised for use with children and adolescents", J Soc Pers Relatsh, 28, pp.1048~1072 (2011)
  37. Manicavasagar V, "A self-report questionnaire for measuring separation anxiety in adulthood", Compr Psychiatry, 44, pp.146~153 (2003)
  38. Hamilton M, "The assessment of anxiety states by rating", Br J Med Psychol, 32, pp.50~55 (1959)
  39. Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiatry, 23, pp.56~62 (1960)
  40. Calzà L, "Hormonal influences on brain ageing quality: Focus on corticotropin releasing hormone-, vasopressin- and oxytocin-immunoreactive neurones in the human brain", J Neural Transm(Vienna), 104, pp.1095~1100 (1997)
  41. Barengolts E, "Oxytocin-an emerging treatment for obesity and dysglycemia : Review of randomized controlled trials and cohort studies", Endocr Pract, 22, pp.885~894 (2016)
  42. Thomas S, "Plasma cortisol and oxytocin levels predict help-seeking intentions for depressive symptoms", Psychoneuroendocrinology, 87, pp.159~165 (2018)
  43. Necati Uzun, "Oxytocin and Vasopressin Levels and Related Factors in Adolescents with Social Phobia and Other Anxiety Disorders", Clinical Psychopharmacology and Neuroscience, 20(2), pp.330~342 (2022), 대한정신약물학회[DOI]
  44. Bendix M, "Plasma oxytocin and personality traits in psychiatric outpatients", Psychoneuroendocrinology, 57, pp.102~110 (2015)
  45. Hoge EA, "Oxytocin levels in social anxiety disorder", CNS Neurosci Ther, 14, pp.165~170 (2008)
  46. Eapen V, "Separation anxiety, attachment and inter-personal representations : Disentangling the role of oxytocin in the perinatal period", PLoS One, 9, pp.e107745~ (2014)
  47. Olff M, "The role of oxytocin in social bonding, stress regulation and mental health : An update on the moderating effects of context and interindividual differences", Psychoneuroendocrinology, 38, pp.1883~1894 (2013)
  48. Tabak BA, "Oxytocin indexes relational distress following interpersonal harms in women", Psychoneuroendocrinology, 36, pp.115~122 (2011)
  49. Scantamburlo G, "Plasma oxytocin levels and anxiety in patients with major depression", Psychoneuroendocrinology, 32, pp.407~410 (2007)
  50. Turner RA, "Preliminary research on plasma oxytocin in normal cycling women : Investigating emotion and interpersonal distress", Psychiatry, 62, pp.97~113 (1999)
  51. Opacka-Juffry J, "Experience of stress in childhood negatively correlates with plasma oxytocin concentration in adult men", Stress, 15, pp.1~10 (2012)
  52. Stuebe AM, "Association between maternal mood and oxytocin response to breastfeeding", J Womens Health(Larchmt), 22, pp.352~361 (2013)
  53. Anderberg UM, "Plasma oxytocin levels in female fibromyalgia syndrome patients", Z Rheumatol, 59, pp.373~379 (2000)
  54. Gordon I, "Oxytocin and cortisol in romantically unattached young adults : Associations with bonding and psychological distress", Psychophysiology, 45, pp.349~352 (2008)
  55. Abbasinazari M, "Plasma oxytocin level and sexual dysfunction in depressed women treated by either fluoxetine or citalopram : A pilot clinical trial", Iran J Pharm Res, 17, pp.408~414 (2018)
  56. Damjanoska KJ, "Chronic fluoxetine differentially affects 5-hydroxytryptamine2A receptor signaling in frontal cortex, oxytocin-and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus", J Pharmacol Exp Ther, 306, pp.563~571 (2003)
  57. Li Q, "Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats", Brain Res, 630, pp.148~156 (1993)
  58. Marar IE, "Vasopressin, oxytocin, corticotrophinreleasing factor, and sodium responses during fluoxetine administration in the rat", Endocrine, 8, pp.13~18 (1998)
  59. Landry M, "Fluoxetine treatment of prepubescent rats produces a selective functional reduction in the 5-HT2A receptor-mediated stimulation of oxytocin", Synapse, 58, pp.102~109 (2005)
  60. Emiliano AB, "The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus : A substrate for SSRIs therapeutic effects?", Neuropsychopharmacology, 32, pp.977~988 (2007)

관련 논문AI추천

Oxytocin and Vasopressin Levels and Related Factors in Adolescents with Social Phobia and Other Anxiety Disordersİbrahim Kılınç, Necati Uzun, Ömer Faruk Akça, Tevfik Balcı대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2022 · 제20권 제2호The Relationship between Plasma Oxytocin Levels and Social Anxiety SymptomsDong-Won Shin, Eun-Jin Kim, Hee-Yeon Woo, Juwon Ha, Kang Seob Oh, Min-Jung Kwon, Se-Won Lim, Young-Chul Shin대한신경정신의학회 · PSYCHIATRY INVESTIGATION2018 · 제15권 제11호The Relationship Between the Oxytocin Level and Rejection Sensitivity, Childhood Traumas, and Attachment Styles in Borderline Personality DisorderBurak Mete, Fatma Kartal, Kerim Uğur, Lut Tamam, Mehmet Emin Demirkol대한신경정신의학회 · PSYCHIATRY INVESTIGATION2022 · 제19권 제3호The Role of Intranasal Oxytocin in Anxiety and Depressive Disorders: A Systematic Review of Randomized Controlled TrialsAlessia Mori, Francesca De Cagna, Gianluca Giovanna, Laura Fusar-Poli, Matteo Rocchetti, Natascia Brondino, Pierluigi Politi, Stefano Damiani대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2019 · 제17권 제1호Investigation of Relaxin-3 Serum Levels in terms of Social Interaction, Communication, and Appetite as a Biomarker in Children with Autismİbrahim Kılınç, Kevser Nalbant, Semih Erden대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2022 · 제20권 제1호An Investgation About the Relationship Between Vasopressin and Oxytocin in Persistent Type Functional Neurological Symptom DisorderBahar Yeşil Örnek, Birgül Elbozan Cumurcu, Esra Porgali Zayman대한신경정신의학회 · PSYCHIATRY INVESTIGATION2021 · 제18권 제10호

이 간행물의 다른 논문 (19건)